NCT07385222

Brief Summary

This single-center, prospective, parallel-group randomized controlled trial evaluated whether extracorporeal magnetic innervation (ExMI) added to pelvic floor muscle training (PFMT) improves pelvic floor muscle function and premature ejaculation symptoms compared with PFMT alone in men with premature ejaculation. Participants were assessed at baseline, week 4, and week 8 using real-time suprapubic ultrasonography and validated patient-reported outcome measures.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
44

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Oct 2019

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 14, 2019

Completed
3.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 8, 2023

Completed
28 days until next milestone

Study Completion

Last participant's last visit for all outcomes

March 8, 2023

Completed
2.9 years until next milestone

First Submitted

Initial submission to the registry

January 27, 2026

Completed
8 days until next milestone

First Posted

Study publicly available on registry

February 4, 2026

Completed
Last Updated

September 11, 2026

Status Verified

September 1, 2026

Enrollment Period

3.3 years

First QC Date

January 27, 2026

Last Update Submit

September 9, 2026

Conditions

Keywords

premature ejaculationpelvic floorpelvic floor muscle trainingmagnetic field therapyultrasonographyextracorporeal magnetic innervation

Outcome Measures

Primary Outcomes (2)

  • Pelvic Floor Muscle Displacement (mm) Assessed by Real-Time Suprapubic Ultrasonography

    Pelvic floor muscle activation was assessed by measuring displacement of the caudal border of the prostate from rest to maximal voluntary pelvic floor contraction using real-time suprapubic ultrasonography. Three contractions were recorded and averaged. Greater displacement indicates greater pelvic floor muscle activation.

    Baseline, Week 4, and Week 8

  • Pelvic floor muscle endurance (seconds) on real-time suprapubic ultrasonography

    Pelvic floor muscle endurance was defined as the duration, in seconds, for which the participant could maintain maximal visible pelvic floor elevation during voluntary contraction under real-time suprapubic ultrasonography. Longer duration indicates greater pelvic floor muscle endurance.

    Baseline, Week 4 and Week 8

Secondary Outcomes (6)

  • Premature Ejaculation Diagnostic Tool (PEDT)

    Baseline, Week 4 and Week 8

  • Brief Sexual Function Inventory (BSFI)

    Baseline, Week 4 and Week 8

  • Five-Item International Index of Erectile Function (IIEF-5)

    Baseline, Week 4 and Week 8

  • World Health Organization Quality of Life-BREF (WHOQOL-BREF) Total Score

    Baseline, Week 4 and Week 8

  • Exploratory WHOQOL-BREF Sexual Satisfaction Item

    Baseline, Week 4, and Week 8

  • +1 more secondary outcomes

Study Arms (2)

Arm A - Pelvic Floor Muscle Training (PFMT)

ACTIVE COMPARATOR

Participants received structured education about pelvic floor anatomy and function and completed an 8-week progressive home-based pelvic floor muscle training program. The program included both slow and fast pelvic floor muscle contractions performed in five sets daily.

Behavioral: Pelvic Floor Muscle Training

Arm B - Pelvic Floor Muscle Training (PFMT) + Extracorporeal Magnetic Innervation (ExMI)

EXPERIMENTAL

Participants completed the same 8-week progressive pelvic floor muscle training program as Arm A and additionally received chair-based extracorporeal magnetic innervation twice weekly for 8 weeks, for a total of 16 sessions.

Behavioral: Pelvic Floor Muscle TrainingDevice: Extracorporeal Magnetic Innervation

Interventions

Participants performed five sets of pelvic floor muscle exercises daily for 8 weeks. Each set included slow and fast contractions. The number of each type of contraction was progressively increased from 10 in week 1, to 20 in week 2, 30 in week 3, and 40 in week 4. During weeks 5-8, each set included 50 slow and 50 fast contractions. Correct pelvic floor contraction was taught and verified using real-time ultrasonography.

Arm A - Pelvic Floor Muscle Training (PFMT)Arm B - Pelvic Floor Muscle Training (PFMT) + Extracorporeal Magnetic Innervation (ExMI)

Extracorporeal magnetic innervation was delivered using the EMD E-6000 MAGTHER system with the participant seated on the treatment chair. Treatment was administered twice weekly for 8 weeks, for a total of 16 sessions. Each session consisted of 10 minutes of intermittent stimulation at 10 Hz, followed by a 1-minute rest period and 10 minutes of intermittent stimulation at 50 Hz. Stimulation intensity was increased to the highest comfortably tolerated level.

Arm B - Pelvic Floor Muscle Training (PFMT) + Extracorporeal Magnetic Innervation (ExMI)

Eligibility Criteria

Age18 Years+
Sexmale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Male adults with premature ejaculation diagnosed by a specialist physician
  • Sexually active
  • Literate and able to understand study instructions
  • Voluntary participation with informed consent
  • Able to cooperate with study assessments and pelvic floor muscle training

You may not qualify if:

  • Medication use or medical conditions likely to affect erection or ejaculation
  • Metabolic, chronic systemic, psychiatric, or significant cardiovascular disorders
  • Alcohol or substance dependence
  • Peyronie's disease
  • Chronic prostatitis
  • Urethritis
  • Active urinary tract infection
  • Documented abnormal semen quality
  • Mental or cognitive problems preventing adequate cooperation with study procedures

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Bolu Abant Izzet Baysal University, Faculty of Health Sciences

Bolu, Merkez, 14030, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Premature BirthEjaculatory DysfunctionPremature Ejaculation

Condition Hierarchy (Ancestors)

Obstetric Labor, PrematureObstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital Diseases, MaleGenital DiseasesSexual Dysfunction, PhysiologicalMale Urogenital DiseasesSexual Dysfunctions, PsychologicalMental Disorders

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Parallel-group randomized controlled trial with two treatment arms
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

January 27, 2026

First Posted

February 4, 2026

Study Start

October 14, 2019

Primary Completion

February 8, 2023

Study Completion

March 8, 2023

Last Updated

September 11, 2026

Record last verified: 2026-09

Data Sharing

IPD Sharing
Will not share

There is no plan for public sharing of individual participant data. The original informed consent and ethics approval did not include public deposition of participant-level data. De-identified data may be considered for sharing on reasonable request, subject to institutional and ethical requirements.

Locations